Respiratory disease in dogs called canine infectious tracheobronchitis (or kennel cough) is a highly contagious disease transmitted by aerosol from infected dogs especially in poorly ventilated kennels, animal shelters, and veterinary hospital [1] . This disease manifests as inflammation of the upper respiratory system. The clinical symptoms of respiratory disease in dogs can be divided into asymptomatic infection, mild illness, and severe illness. The mild illness is characterized by dry, hacking cough, increasing mucus formation and gagging whereas dogs with severe illness tend to be clinically ill, febrile, anorexic, depress, and die as a result of multiple infection, immuno-suppression, or lack of vaccination [2] . The potential etiological pathogens of respiratory disease in dogs are canine distemper virus, canine adeno virus and canine para-influenza-virus [3] .
Canine adeno virus (CAV) is a double stranded DNA virus classified into the Adenoviridae family. It can be divided into two types, canine adenovirus type 1 (CAV-1) and canine adenovirus type 2 (CAV-2), which target different cell types. CAV-1 preferentially infects vascular endothelial cells, hepatic cells, and renal parenchymal cells, whereas the main targets of CAV-2 are epithelial cells in the respiratory tract and intestine [4, 5] . Therefore, CAV-2 is one of the causes of respiratory disease in dogs and has rapidly spread in dogs lacking immunity against CAV [6] .
Canine distemper virus (CDV) is a negative single stranded RNA virus belonging to the paramyxoviridae family, which is the causative agent for serious disease in dogs [7] . The main targets of CDA are mucous membranes and lymphoid tissues. CAD is transmitted by aerosol and then replicates in lymphatic tissues of the host's respiratory tract. Subsequently, the progeny viruses spread to other organs such as lower respiratory tract, gastrointestinal tract, lymphatic system, urinary bladder, and central nervous system because of subclinical infection or complex infection. The clinical signs were associated with respiratory and enteric diseases of infected dogs [8] .
Canine parainfluenza virus (CPIV) is a negative single stranded RNA virus categorized into the Paramyxoviridae family, which is ubiquitous in canine populations. Usually, CPIV infects the upper respiratory tract but can sometimes be recovered from lungs, spleen, kidney, and liver of infected dogs. This virus replicates mainly in the epithelial cells of the nasal mucosa, large bronchi, pharynx trachea, and regional lymph nodes. It has been considered an important cause of kennel cough commonly isolated from outbreaks of the disease. The symptoms of the disease are mild or subclinical, but in some cases, CPIV infection may occur simultaneously with other viral or bacterial agents leading to more severe signs of kennel cough [9] .
Recently, canine influenza A virus has been reported to infect and cause respiratory illness in dogs. In 2004, canine influenza (H3N8) has emerged in the United States because of direct transmission from equine influenza virus subtype H3N8 to greyhounds [10] . In 2005, CIV (H3N8) were isolated from nongreyhound dogs with respiratory disease in Florida [11] . Moreover, another subtype of canine influenza virus has recently emerged in Korea in 2007, which originated from avian influenza subtype H3N2 [12] . CIV is also the cause of respiratory diseases ranging from mild to severe illness. Mild illness includes fever, cough, nasal discharge, sneezing whereas severe illness consists of severe nasal discharge, and death resulting from hemorrhage in the respiratory tracts such as lungs, mediastinum, and pleural cavity [10] .
At present, vaccines against CDV, CAV, and CPIV are readily available. However, infectious tracheobronchitis in dogs is still observed [13] . In 2009, pandemic influenza H1N1 2009 has been found in a 13-year-old dog in Bedford Hills, New York. The owner was ill with positive pandemic influenza H1N1 2009 virus after that the dog became sick. The clinical symptoms in dog were lethargic, coughing, refused feeding, and high grade fever. Investigation of the laboratory revealed that the dog was negative canine influenza virus (H3N8) but positive for pandemic influenza H1N1 2009 [14] . Moreover, there were two dogs in Beijing, China with detectable pandemic influenza H1N1 2009. It is possible that pandemic influenza H1N1 2009 can transmit the virus from human to dogs [15] . The pandemic influenza H1N1 2009 virus can infect cat, turkey, ferret, pig and human [14] . In Thailand, the pandemic influenza H1N1 2009 has also occurred since May 2009. The details have been reported elsewhere [16] . However, pandemic influenza H1N1 2009 virus in dogs has not been reported in Thailand. In this study, a sensitive nested reverse transcription-polymerase chain reaction (RT-PCR) was performed to detect respiratory virus including CDV (CDV), CPIV, CAV, and CIV in dogs with respiratory diseases as well as healthy dogs in Thailand between 2008 and 2009. The prevalence data obtained from this study may be useful for outbreak prevention and vaccine management as well as to raise awareness of potential transmission of the newly emerged CIV to humans.
Materials and methods

Clinical samples
Nasal 
Specific primer designs
Nucleotide sequences of the M gene of influenza A virus, E3 gene of CAV, NP genes of CDV, NP gene of canine parainfluenza virus, and canine GAPDH gene (internal control) were obtained from the Gen Bank database. More than 40 sequences of each target gene were subjected to multiple alignments using the BioEdit Sequence Alignment Editor Version 7.0.9.0 [17] . The conserved regions were selected as candidate primers for the in silico specificity test by BLAST analysis (available online at http:// blast.ncbi.nlm.nih.gov/Blast.cgi) to ensure the specificity of the selected primers without crossamplification of canine genes. Subsequently, the candidate primers were evaluated by Oligos primer design software version 9.1 (Ruslan Kalendar, Institute of Biotechnology, University of Helsinki, Finland) to ensure absence of primer-dimers, self-pairing and secondary structure. Each primer pair was tested for specificity against viral DNA/RNA extracted from NOBIVAC DHPPi live vaccine (Intervet International BV, Boxmeer, Holland) containing CDV, VAV-2, canine parvovirus, and CPIV. All specific primers used in this study were synthesized by BioDesign Co, Ltd (Pathumthani, Thailand) and are summarized in Table 1 .
Detection of canine respiratory viruses by nested PCR amplification
The reaction mixture for the first round of nested PCR included 10 μl of 2.5x Eppendorf MasterMix O C for seven minutes. The second round of nested PCR was performed using a similar reaction mixture and thermal cycling profile as described above but changing the primer pair and using the PCR product from the first round as a template for nested amplification. The PCR products obtained from the second round of amplification were analyzed by 2% agarose gel electropholysis at 100 volts, for 40 minutes. Subsequently, the agarose gel was stained with ethidium bromide and visualized under UV transillumination. The expected size of each amplified product is summarized in Table 1 and displayed in Fig. 1 .
DNA purification and nucleotide sequencing
The PCR products of interest were purified by using the Perfect Prep Gel Cleanup Kit (Eppendorf, Hamburg, Germany) following the company's protocol with the final elution performed in 40 μl of elution buffer. The purified DNA was subjected to nucleotide sequence determination by a commercially available sequencing service (1st BASE Laboratories, Selangor Darul Ehsan, Malaysia).
Sequencing analysis
Nucleotide sequences were analyzed by BLAST analysis tool (http://blast.ncbi.nlm.nih.gov/Blast.cgi), BioEdit Sequence Alignment Editor version 7.0.9.0 [17] and Chromas Lite version 2.01 (Technelysium Pty, Ltd).
Result
Detection of canine respiratory viruses by nested PCR
Amplification of canine DNA/cDNA specimens by nested PCR yielded DNA bands of 350, 207, 220 and 180 bp indicating CAV, CIV, CDV, and CPIV, respectively (Fig. 1) . The results showed that the bands of the positive samples were exactly the same size as those found in the positive control live vaccine from NOBIVAC DHPPi (Intervet International BV, Boxmeer, Holland) without any non-specific band indicating high specificity of the primers used for canine respiratory virus detection by nested PCR. 
Prevalence of canine respiratory virus infection in Thailand
Single infection with canine respiratory viruses. Based on amplification of canine DNA/cDNA specimens by nested PCR and confirmation by nucleotide sequencing, CAV was not detected in healthy dogs (0%) whereas it was found in 10 of 109 (9.17%) specimens obtained from dogs with respiratory symptoms. Interestingly, CIV was detected in three of 102 (2.94%) specimens from healthy dogs and 3 of 109 (2.75%) specimens obtained from dogs with respiratory disease. Surprisingly, CDV was detected in three of 102 (2.94%) and 2 of 109 (1.83%) clinical specimens obtained from healthy dogs and dogs with respiratory symptoms, respectively. Finally, CPIV had infected one of 102 (0.98%) healthy dogs and 13 of 109 (11.93%) dogs with respiratory diseases ( Table 2) .
Multiple infections with canine respiratory viruses. In healthy dogs, co-infection was detected in only one of 102 (0.98%) specimens infected with CPIV and CDV. On the other hand, dogs with respiratory symptoms displayed co-infection with CIV and CAV in two of 109 (1.83%) specimens, with CIV and CPIV in one of 109 (0.92%) cases, and with CAV and CPIV in two of 109 (1.83%) samples. Triple infection was found only in dogs with respiratory diseases in that one sample (0.92%) was infected with CAV, CDV and CPIV ( Table 2) .
Clinical symptoms observed in dogs with respiratory diseases. The clinical symptoms observed in dogs with respiratory diseases manifested as signs of illness including severe nasal discharge or upper respiratory tract infection in dogs infected with adenovirus. Dogs infected with CIV might display severe nasal discharge, mucous nasal discharge, sneezing, cough or respiratory tract infection. Dogs suffering from canine distemper virus infection might show severe nasal discharge, mucous nasal discharge, dyspnea, cough or sneezing. Dogs infected with CPIV might exhibit cough, dry cough, severe nasal discharge, purulent nasal discharge, or bronchitis. The clinical symptoms observed in the multiple-infected dogs were similar but the illness could potentially become more severe. 
Discussion
This study investigated the prevalence of canine respiratory viruses including CIV, CAV, CDV, and CPIV in nasal swab samples of 102 healthy dogs and 109 dogs with respiratory diseases based on sensitive and specific nested PCR amplification and further confirmation and identification by nucleotide sequencing. The results of nested PCR showed that the primers designed and used in this study yielded high specificity without any crossamplification of canine genes or unexpected nonspecific amplification. Moreover, these primers yielded clearly defined DNA bands, which were also suitable for further direct nucleotide sequencing without requiring additional DNA cloning. Furthermore, the specific primers designed for each canine respiratory virus can be used with the same PCR reaction mixtures and thermo cycling profile. Therefore, the primers and conditions of nested PCR established in this study would be useful and suitable for further large-scale screening for canine respiratory viruses.
The prevalence of canine adenovirus in Thailand could not be determined in healthy dogs whereas the virus was detected in approximately 9.17% of dogs with respiratory diseases. CAV-2 positive cases in Thailand were more numerous than in Japan [18] where about 2.9% had been reported, indicating that Thai dogs may be at higher risk for infection with CAV than dogs in Japan. Approximately 2.94% of healthy dogs and 1.83% of dogs with respiratory diseases in Thailand were infected with CDV. This is comparable with previous study reported that the prevalence of canine distemper virus in Japan [18] was about 1.5% in dogs with respiratory signs. CPIV was found in 0.98% of healthy and 11.93% of dogs with respiratory disease. Based on pervious studies, the prevalence of CPIV in dogs with a history of respiratory disease was 7.4% in Japan [18] and 19.09% in USA [13] . Both publications reported that CPIV accounted for the highest prevalence of canine respiratory virus in dogs with respiratory disease, which is also concordant with the result obtained from this study.
In this study, the prevalence of CIV was approximately 2.94% in healthy dogs indicating that healthy dogs can be asymptomatically infected with CIV and might be able to act as a carrier of this virus. The virus was also found in 2.75% of dogs with respiratory symptoms including nasal discharge, mucous nasal discharge, sneezing, cough, or respiratory tract infection. The severity of symptoms observed in dogs with respiratory disease in Thailand appears to be less than that found in Florida, United States and South Korea [10] [11] [12] where infected dogs exhibited more severe respiratory diseases and died. This indicates that the sub-types of CIV detected in Thailand may be different from H3N8 or H3N2, which had been found in Florida and South Korea, respectively. Therefore, sub-types of the CIV isolated from both healthy dogs and dogs with respiratory symptoms in Thailand should be further investigated to predict the severity of infection and the potential for cross-infection to humans. In conclusion, this study described the prevalence of canine respiratory viruses including CIV, CAV, CDV, and CPIV in nasal swab samples of 102 healthy dogs and 109 dogs with respiratory diseases based on the in-house nested PCR detection method and further confirmation by nucleotide sequencing. The prevalence data obtained from this study may be useful for outbreak prevention and vaccine management as well as to raise awareness of potential transmission of the newly emerged CIV to humans.
